Antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin head region of pandemic H1N1 influenza virus play detrimental roles in H1N1-infected mice

Frontiers in Immunology

Volumn 8, Issue MAR, 2017, Pages

  Ye, Zi Wei ^a   Yuan, Shuofeng ^a   Poon, Kwok Man ^a   Wen, Lei ^a   Yang, Dong ^a   Sun, Zehua ^a   Li, Cun ^a   Hu, Meng ^a   Shuai, Huiping ^a   Zhou, Jie ^a,b   Zhang, Mei Yun ^a   Zheng, Bo Jian ^a   Chu, Hin ^a,b   Yuen, Kwok Yung ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antibody dependent cell mediated cytotoxicity; H1N1 influenza virus; Hemagglutinin; Lung damage; Mice

Indexed keywords

EPITOPE; GAMMA INTERFERON; HEMAGGLUTININ; INFLUENZA VACCINE; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR;

AFFINITY CHROMATOGRAPHY; ANIMAL CELL; ANIMAL MODEL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN FUNCTION; ARTICLE; CELL INFILTRATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CROSS PRESENTATION; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HISTOPATHOLOGY; INFLUENZA A (H1N1); LUNG INJURY; MORTALITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD;

EID: 85017191342     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00317     Document Type: Article

References (47)

1. Hayden FG, de Jong MD. Emerging influenza antiviral resistance threats. J Infect Dis (2011) 203(1):6-10. doi: 10.1093/infdis/jiq012
2. Treanor J. Influenza vaccine-outmaneuvering antigenic shift and drift. N Engl J Med (2004) 350(3):218-20. doi:10.1056/NEJMp038238
3. Belongia EA, Simpson MD, King JP, Sundaram ME, Kelley NS, Osterholm MT, et al. Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. Lancet Infect Dis (2016) 16(8):942-51. doi:10.1016/S1473-3099(16)00129-8
4. Jegaskanda S, Reading PC, Kent SJ. Influenza-specific antibody-dependent cellular cytotoxicity: toward a universal influenza vaccine. J Immunol (2014) 193(2):469-75. doi:10.4049/jimmunol.1400432
5. Chung AW, Navis M, Isitman G, Centre R, Finlayson R, Bloch M, et al. Activation of NK cells by ADCC responses during early HIV infection. Viral Immunol (2011) 24(2):171-5. doi:10.1089/vim.2010.0108
6. DiLillo DJ, Tan GS, Palese P, Ravetch JV. Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc?R interactions for protection against influenza virus in vivo. Nat Med (2014) 20(2):143-51. doi:10.1038/nm.3443
7. Jegerlehner A, Schmitz N, Storni T, Bachmann MF. Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity. J Immunol (2004) 172(9):5598-605. doi:10.4049/jimmunol.172.9.5598
8. Simhadri VR, Dimitrova M, Mariano JL, Zenarruzabeitia O, Zhong W, Ozawa T, et al. A human anti-M2 antibody mediates antibody-dependent cell-mediated cytotoxicity (ADCC) and cytokine secretion by resting and cytokine-preactivated natural killer (NK) cells. PLoS One (2015) 10(4):e0124677. doi:10.1371/journal.pone.0124677
9. Vanderven HA, Ana-Sosa-Batiz F, Jegaskanda S, Rockman S, Laurie K, Barr I, et al. What lies beneath: antibody dependent natural killer cell activation by antibodies to internal influenza virus proteins. EBioMedicine (2016) 8:277-90. doi:10.1016/j.ebiom.2016.04.029
10. Shi Y, Wu Y, Zhang W, Qi J, Gao GF. Enabling the 'host jump': structural determinants of receptor-binding specificity in influenza A viruses. Nat Rev Microbiol (2014) 12(12):822-31. doi:10.1038/nrmicro3362
11. Srivastava V, Yang Z, Hung IF, Xu J, Zheng B, Zhang MY. Identification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus. J Virol (2013) 87(10):5831-40. doi:10.1128/JVI.00273-13
12. He W, Tan GS, Mullarkey CE, Lee AJ, Lam MM, Krammer F, et al. Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus. Proc Natl Acad Sci U S A (2016) 113(42):11931-6. doi:10.1073/pnas.1609316113
13. Chu H, Zhou J, Wong BH, Li C, Chan JF, Cheng ZS, et al. Middle east respiratory syndrome coronavirus efficiently infects human primary T lymphocytes and activates the extrinsic and intrinsic apoptosis pathways. J Infect Dis (2016) 213(6):904-14. doi:10.1093/infdis/jiv380
14. Zhang MY, Vu BK, Choudhary A, Lu H, Humbert M, Ong H, et al. Cross-reactive human immunodeficiency virus type 1-neutralizing human monoclonal antibody that recognizes a novel conformational epitope on gp41 and lacks reactivity against self-antigens. J Virol (2008) 82(14):6869-79. doi:10.1128/JVI.00033-08
15. Zheng B, Chan KH, Zhang AJ, Zhou J, Chan CC, Poon VK, et al. D225G mutation in hemagglutinin of pandemic influenza H1N1 (2009) virus enhances virulence in mice. Exp Biol Med (Maywood) (2010) 235(8):981-8. doi:10.1258/ebm.2010.010071
16. Zheng BJ, Chan KW, Lin YP, Zhao GY, Chan C, Zhang HJ, et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus. Proc Natl Acad Sci U S A (2008) 105(23):8091-6. doi:10.1073/pnas.0711942105
17. Yuan S, Chu H, Zhang K, Ye J, Singh K, Kao RY, et al. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication. J Antimicrob Chemother (2016) 71(9):2489-97. doi:10.1093/jac/dkw194
18. Yuan S, Chu H, Ye J, Singh K, Ye Z, Zhao H, et al. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface. Antiviral Res (2017) 137:58-66. doi:10.1016/j.antiviral.2016.11.005
19. Yuan S, Zhang N, Singh K, Shuai H, Chu H, Zhou J, et al. Cross-protection of influenza A virus infection by a DNA aptamer targeting the PA endonuclease domain. Antimicrob Agents Chemother (2015) 59(7):4082-93. doi:10.1128/AAC.00306-15
20. Yuan S, Chu H, Ye J, Hu M, Singh K, Chow BK, et al. Peptide-mediated interference of PB2-eIF4G1 interaction inhibits influenza A viruses' replication in vitro and in vivo. ACS Infect Dis (2016) 2(7):471-7. doi:10.1021/acsinfecdis.6b00064
21. van den Brand JM, Stittelaar KJ, van Amerongen G, Rimmelzwaan GF, Simon J, de Wit E, et al. Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis (2010) 201(7):993-9. doi:10.1086/651132
22. Sun S, Zhao G, Xiao W, Hu J, Guo Y, Yu H, et al. Age-related sensitivity and pathological differences in infections by 2009 pandemic influenza A (H1N1) virus. Virol J (2011) 8:52. doi:10.1186/1743-422X-8-52
23. Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, Enelow RI, et al. Critical role of IL-17RA in immunopathology of influenza infection. J Immunol (2009) 183(8):5301-10. doi:10.4049/jimmunol.0900995
24. Wang X, Chan CC, Yang M, Deng J, Poon VK, Leung VH, et al. A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection. Cell Mol Immunol (2011) 8(6):462-8. doi:10.1038/cmi.2011.38
25. Chan CM, Chu H, Wang Y, Wong BH, Zhao X, Zhou J, et al. Carcinoembryonic antigen-related cell adhesion molecule 5 is an important surface attachment factor that facilitates entry of middle east respiratory syndrome coronavirus. J Virol (2016) 90(20):9114-27. doi:10.1128/JVI.01133-16
26. Zhou J, Chu H, Li C, Wong BH, Cheng ZS, Poon VK, et al. Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis. J Infect Dis (2014) 209(9):1331-42. doi:10.1093/infdis/jit504
27. Chu H, Zhou J, Wong BH, Li C, Cheng ZS, Lin X, et al. Productive replication of Middle East respiratory syndrome coronavirus in monocyte-derived dendritic cells modulates innate immune response. Virology (2014) 45(4-455):197-205. doi:10.1016/j.virol.2014.02.018
28. Wang W, Erbe AK, Hank JA, Morris ZS, Sondel PM. NK cell-mediated antibody-dependent cellular cytotoxicity in cancer immunotherapy. Front Immunol (2015) 6:368. doi:10.3389/fimmu.2015.00368
29. Hassane M, Paget C. "Universal flu vaccine": can NK cell-mediated ADCC tip the scales? EBioMedicine (2016) 8:18-9. doi:10.1016/j.ebiom.2016.05.042
30. Jegaskanda S, Vandenberg K, Laurie KL, Loh L, Kramski M, Winnall WR, et al. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza viruses. J Infect Dis (2014) 210(11):1811-22. doi:10.1093/infdis/jiu334
31. Zhou G, Juang SW, Kane KP. NK cells exacerbate the pathology of influenza virus infection in mice. Eur J Immunol (2013) 43(4):929-38. doi:10.1002/eji.201242620
32. Cox F, Baart M, Huizingh J, Tolboom J, Dekking L, Goudsmit J, et al. Protection against H5N1 influenza virus induced by matrix-M adjuvanted seasonal virosomal vaccine in mice requires both antibodies and T cells. PLoS One (2015) 10(12):e0145243. doi:10.1371/journal.pone.0145243
33. Jegaskanda S, Co MD, Cruz J, Subbarao K, Ennis FA, Terajima M. Human seasonal influenza A viruses induce H7N9-cross-reactive antibody-dependent cellular cytotoxicity (ADCC) antibodies that are directed towards the nucleoprotein. J Infect Dis (2017) 1-6. doi:10.1093/infdis/jiw629
34. Schroeder HW Jr. Similarity and divergence in the development and expression of the mouse and human antibody repertoires. Dev Comp Immunol (2006) 30(1-2):119-35. doi:10.1016/j.dci.2005.06.006
35. Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol (2004) 172(5):2731-8. doi:10.4049/jimmunol.172.5.2731
36. Vossenkamper A, Spencer J. Transitional B cells: how well are the checkpoints for specificity understood? Arch Immunol Ther Exp (Warsz) (2011) 59(5):379-84. doi:10.1007/s00005-011-0135-0
37. Benitez A, Weldon AJ, Tatosyan L, Velkuru V, Lee S, Milford TA, et al. Differences in mouse and human nonmemory B cell pools. J Immunol (2014) 192(10):4610-9. doi:10.4049/jimmunol.1300692
38. Fehniger TA, Cai SF, Cao X, Bredemeyer AJ, Presti RM, French AR, et al. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity (2007) 26(6):798-811. doi:10.1016/j.immuni.2007.04.010
39. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol (2001) 22(11):633-40. doi:10.1016/S1471-4906(01)02060-9
40. Bratke K, Kuepper M, Bade B, Virchow JC Jr, Luttmann W. Differential expression of human granzymes A, B, and K in natural killer cells and during CD8+ T cell differentiation in peripheral blood. Eur J Immunol (2005) 35(9):2608-16. doi:10.1002/eji.200526122
41. Mesman AW, Westerhuis BM, Ten Hulscher HI, Jacobi RH, de Bruin E, van Beek J, et al. Influenza virus A(H1N1)2009 antibody-dependent cellular cytotoxicity in young children prior to the H1N1 pandemic. J Gen Virol (2016) 97(9):2157-65. doi:10.1099/jgv.0.000552
42. Zhong W, Liu F, Wilson JR, Holiday C, Li ZN, Bai Y, et al. Antibody-dependent cell-mediated cytotoxicity to hemagglutinin of influenza A viruses after influenza vaccination in humans. Open Forum Infect Dis (2016) 3(2):ofw102. doi:10.1093/ofid/ofw102
43. Jegaskanda S, Job ER, Kramski M, Laurie K, Isitman G, de Rose R, et al. Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies. J Immunol (2013) 190(4):1837-48. doi:10.4049/jimmunol.1201574
44. Krammer F. The quest for a universal flu vaccine: headless HA 2.0. Cell Host Microbe (2015) 18(4):395-7. doi:10.1016/j.chom.2015.10.003
45. Graves PN, Schulman JL, Young JF, Palese P. Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants. Virology (1983) 126(1):106-16. doi:10.1016/0042-6822(83)90465-8
46. Wohlbold TJ, Nachbagauer R, Margine I, Tan GS, Hirsh A, Krammer F. Vaccination with soluble headless hemagglutinin protects mice from challenge with divergent influenza viruses. Vaccine (2015) 33(29):3314-21. doi:10.1016/j.vaccine.2015.05.038
47. Valkenburg SA, Mallajosyula VV, Li OT, Chin AW, Carnell G, Temperton N, et al. Stalking influenza by vaccination with pre-fusion headless HA mini-stem. Sci Rep (2016) 6:22666. doi:10.1038/srep22666